ANTIBODY-TETRAZINE CONJUGATES

63/391,136 | U.S. Patent Application

Interested in this case?

Request a Demo Track this case, and find millions of cases like it, let us show you how.
Location ELECTRONIC
Filed July 21, 2022
Case Type Provisional
Status Provisional Application Expired
Child 18/705,504 Pending
Child PCT/US22/78995 Published
Last Updated: 1 month, 3 weeks ago
Date # Transaction
7/23/2023EXPIRED PROVISIONAL
8/3/2022Filing Receipt
8/3/2022Email Notification
8/3/2022Application ready for PDX access by participating foreign offices
8/3/2022Application Is Now Complete
8/3/2022Filing Receipt
8/2/2022Application Dispatched from OIPE
8/2/2022Applicant Has Filed a Verified Statement of Small Entity Status in Compliance with 37 CFR 1.27
7/21/2022Power of Attorney Written Arguments, Opinions, Incoming amendments, Papers received from applicants
7/21/2022Specification Application Documents
7/21/2022Claims Application Documents
7/21/2022Abstract Application Documents
7/21/2022Provisional Cover Sheet (SB16)
7/21/2022Fee Worksheet (SB06) In-house documents including Examiner Notes/Search Results
7/21/2022Electronic Filing System Acknowledgment Receipt Office Actions Communications
7/21/2022Drawings-only black and white line drawings Application Documents
7/21/2022PTO/SB/69-Authorize EPO Access to Search Results
7/21/2022Applicants have given acceptable permission for participating foreign
7/21/2022Entity Status Set To Undiscounted (Initial Default Setting or Status Change)
7/21/2022Initial Exam Team nn